2022 Q4 Form 10-Q Financial Statement

#000149315222032059 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $159.0K $134.0K $23.00K
YoY Change 140.91% 482.61% 91.67%
Cost Of Revenue $352.0K $430.0K $211.0K
YoY Change 22.65% 103.79% 37.91%
Gross Profit -$193.0K -$296.0K -$188.0K
YoY Change -12.67% 57.45% 33.33%
Gross Profit Margin -121.38% -220.9% -817.39%
Selling, General & Admin $397.0K $981.0K $1.782M
YoY Change -80.01% -44.95% 139.84%
% of Gross Profit
Research & Development $1.174M $1.048M $596.0K
YoY Change 80.06% 75.84% 313.89%
% of Gross Profit
Depreciation & Amortization $91.00K $57.00K $24.00K
YoY Change 78.43% 137.5% 0.0%
% of Gross Profit
Operating Expenses $1.564M $2.029M $2.375M
YoY Change -40.6% -14.57% 167.76%
Operating Profit -$1.757M -$2.325M -$2.563M
YoY Change -38.44% -9.29% 149.32%
Interest Expense $93.00K $73.00K $1.000K
YoY Change -24.39% 7200.0% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.664M -$2.244M -$2.562M
YoY Change -39.07% -12.41% 149.46%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.664M -$2.244M -$2.562M
YoY Change -39.07% -12.41% 149.46%
Net Earnings / Revenue -1046.54% -1674.63% -11139.13%
Basic Earnings Per Share -$0.32 -$0.37
Diluted Earnings Per Share -$0.23 -$315.1K -$369.7K
COMMON SHARES
Basic Shares Outstanding 7.122M shares 7.122M shares 6.930M shares
Diluted Shares Outstanding 7.122M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.15M $15.17M $19.73M
YoY Change -32.91% -23.12% 526.19%
Cash & Equivalents $10.10M $2.586M $19.73M
Short-Term Investments $3.047M $12.58M
Other Short-Term Assets $281.0K $272.0K $537.0K
YoY Change -36.57% -49.35% 93.86%
Inventory $630.0K $652.0K $145.0K
Prepaid Expenses
Receivables $60.00K $15.00K $19.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.12M $16.10M $20.43M
YoY Change -30.16% -21.16% 313.48%
LONG-TERM ASSETS
Property, Plant & Equipment $648.0K $708.0K $1.126M
YoY Change -17.03% -37.12% 205.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $328.0K $325.0K $416.0K
YoY Change -17.17% -21.88% 27.22%
Total Long-Term Assets $2.778M $2.913M $3.176M
YoY Change -16.68% -8.28% 356.32%
TOTAL ASSETS
Total Short-Term Assets $14.12M $16.10M $20.43M
Total Long-Term Assets $2.778M $2.913M $3.176M
Total Assets $16.90M $19.02M $23.60M
YoY Change -28.25% -19.43% 318.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $297.0K $366.0K $201.0K
YoY Change 188.35% 82.09% 11.05%
Accrued Expenses $778.0K $694.0K $880.0K
YoY Change -5.24% -21.14% 49.41%
Deferred Revenue $1.426M $1.429M
YoY Change 312.14%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.559M $2.556M $1.106M
YoY Change 95.49% 131.1% -43.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.550M $2.733M $1.894M
YoY Change -2.71% 44.3% 436.54%
Total Long-Term Liabilities $2.550M $2.733M $1.894M
YoY Change -2.71% 44.3% 436.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.559M $2.556M $1.106M
Total Long-Term Liabilities $2.550M $2.733M $1.894M
Total Liabilities $5.109M $5.289M $3.000M
YoY Change 30.0% 76.3% 29.09%
SHAREHOLDERS EQUITY
Retained Earnings -$24.76M -$23.10M
YoY Change 61.91%
Common Stock $36.55M $36.83M
YoY Change 4.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.79M $13.73M $20.60M
YoY Change
Total Liabilities & Shareholders Equity $16.90M $19.02M $23.60M
YoY Change -28.25% -19.43% 318.77%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.664M -$2.244M -$2.562M
YoY Change -39.07% -12.41% 149.46%
Depreciation, Depletion And Amortization $91.00K $57.00K $24.00K
YoY Change 78.43% 137.5% 0.0%
Cash From Operating Activities -$1.988M -$1.709M -$1.650M
YoY Change 68.19% 3.58% 281.06%
INVESTING ACTIVITIES
Capital Expenditures $31.00K $45.00K -$313.0K
YoY Change -127.68% -114.38% 1017.86%
Acquisitions
YoY Change
Other Investing Activities $9.500M -$3.000M
YoY Change -186.36%
Cash From Investing Activities $9.469M -$3.045M -$313.0K
YoY Change -185.21% 872.84% 1017.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -95.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.988M -$1.709M -1.650M
Cash From Investing Activities 9.469M -$3.045M -313.0K
Cash From Financing Activities 0.000 -95.00K
Net Change In Cash 7.481M -$4.754M -2.058M
YoY Change -166.43% 131.0%
FREE CASH FLOW
Cash From Operating Activities -$1.988M -$1.709M -$1.650M
Capital Expenditures $31.00K $45.00K -$313.0K
Free Cash Flow -$2.019M -$1.754M -$1.337M
YoY Change 88.69% 31.19% 230.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001577445
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
SCTC Round Up Shares Due To Reverse Stock Split
RoundUpSharesDueToReverseStockSplit
usd
CY2022Q3 us-gaap Severance Costs1
SeveranceCosts1
usd
CY2021Q3 us-gaap Severance Costs1
SeveranceCosts1
usd
SCTC Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
usd
CY2021Q3 SCTC Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
usd
SCTC Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
usd
CY2021Q3 SCTC Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2021Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
SCTC Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
usd
CY2021Q3 SCTC Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
usd
SCTC Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
usd
CY2022Q3 SCTC Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
usd
CY2021Q3 SCTC Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
usd
SCTC Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
usd
CY2021Q3 SCTC Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
usd
SCTC Issuance Expenses
IssuanceExpenses
usd
CY2022Q3 SCTC Issuance Expenses
IssuanceExpenses
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2021Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
SCTC Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
CY2022Q3 SCTC Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
CY2021Q3 SCTC Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
SCTC Non Cash Issuance Expenses
NonCashIssuanceExpenses
usd
CY2022Q3 SCTC Non Cash Issuance Expenses
NonCashIssuanceExpenses
usd
CY2021Q3 SCTC Non Cash Issuance Expenses
NonCashIssuanceExpenses
usd
SCTC Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
usd
CY2021Q3 SCTC Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
usd
SCTC Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
usd
CY2022Q3 SCTC Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
usd
SCTC Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
usd
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
usd
CY2021 SCTC Contract With Customer Liability Revenue Recognized During Period Development Services
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriodDevelopmentServices
usd
CY2022Q3 us-gaap Assets
Assets
19017000 usd
CY2021Q4 us-gaap Assets
Assets
23546000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
366000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-188920
dei Entity Registrant Name
EntityRegistrantName
SCOUTCAM INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4257143
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 7A
dei Entity Address Address Line2
EntityAddressAddressLine2
Industrial Park
dei Entity Address Address Line3
EntityAddressAddressLine3
P.O. Box 3030
dei Entity Address City Or Town
EntityAddressCityOrTown
Omer
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
8496500
dei City Area Code
CityAreaCode
+972
dei Local Phone Number
LocalPhoneNumber
73 370-4691
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7121737 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2586000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8581000 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
12579000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
11013000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
652000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
167000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
272000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
443000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
16104000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20212000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1555000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1675000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
708000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
781000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
325000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
482000 usd
CY2022Q3 SCTC Severance Pay Asset
SeverancePayAsset
325000 usd
CY2021Q4 SCTC Severance Pay Asset
SeverancePayAsset
396000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2913000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3334000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
103000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1429000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
346000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
192000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
256000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
352000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
355000 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
67000 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
39000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
150000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
210000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2556000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1309000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2324000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2074000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
203000 usd
CY2022Q3 SCTC Liability For Severance Pay
LiabilityForSeverancePay
324000 usd
CY2021Q4 SCTC Liability For Severance Pay
LiabilityForSeverancePay
344000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2733000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2621000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
5289000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3930000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7121737 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7121737 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7121737 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7121737 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
7000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36819000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
34903000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23098000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15294000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13728000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19616000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19017000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23546000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
506000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
134000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-183000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1279000 usd
us-gaap Cost Of Revenue
CostOfRevenue
821000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
430000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
211000 usd
us-gaap Gross Profit
GrossProfit
-773000 usd
us-gaap Gross Profit
GrossProfit
-500000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-296000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
-188000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3023000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1193000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1048000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
550000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
617000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
629000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
171000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
225000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3262000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3931000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
810000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1603000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7675000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6253000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2325000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2566000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
23000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
8000 usd
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000 usd
SCTC Financing Income Expenses Net
FinancingIncomeExpensesNet
-152000 usd
SCTC Financing Income Expenses Net
FinancingIncomeExpensesNet
-6000 usd
CY2022Q3 SCTC Financing Income Expenses Net
FinancingIncomeExpensesNet
73000 usd
CY2021Q3 SCTC Financing Income Expenses Net
FinancingIncomeExpensesNet
1000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7804000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6256000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2244000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2562000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7122000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5968000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7122000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6930000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19616000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1916000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7804000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13728000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
15513000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
459000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2244000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13728000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3964000 usd
SCTC Stock Issued During Period Value Of Shares And Warrants
StockIssuedDuringPeriodValueOfSharesAndWarrants
19118000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1317000 usd
SCTC Exercise Of Warrants
ExerciseOfWarrants
2459000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6256000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
20602000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
22482000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
682000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2562000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
20602000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7804000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6256000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2244000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2562000 usd
us-gaap Depreciation
Depreciation
160000 usd
us-gaap Depreciation
Depreciation
63000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
57000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
24000 usd
us-gaap Severance Costs1
SeveranceCosts1
51000 usd
us-gaap Severance Costs1
SeveranceCosts1
-56000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1916000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1317000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
459000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
682000 usd
SCTC Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
52000 usd
CY2022Q3 SCTC Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
2000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-301000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
12000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26000 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000 usd
SCTC Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
66000 usd
CY2022Q3 SCTC Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
43000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-84000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
485000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-99000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
43000 usd
SCTC Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
210000 usd
CY2022Q3 SCTC Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
78000 usd
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-58000 usd
CY2021Q3 SCTC Issuance Expenses
IssuanceExpenses
95000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2459000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-28000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-72000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-45000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-12000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-171000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
170000 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-138000 usd
CY2021Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-339000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
263000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
122000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-120000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
504000 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-60000 usd
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
124000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1333000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
529000 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-102000 usd
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
34000 usd
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-24000 usd
CY2021Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-60000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
60000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-145000 usd
CY2021Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
82000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4107000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4704000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1709000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1650000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
483000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000 usd
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
313000 usd
SCTC Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
5000000 usd
SCTC Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
6500000 usd
CY2022Q3 SCTC Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
3000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1587000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-483000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3045000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-313000 usd
SCTC Issuance Expenses
IssuanceExpenses
50000 usd
SCTC Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
19118000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5694000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16340000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21527000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4754000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2058000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-301000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8581000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3373000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7314000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21775000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2586000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19725000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2586000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19725000 usd
SCTC Non Cash Issuance Expenses
NonCashIssuanceExpenses
45000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
118000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
423000 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
37000 usd
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
64000 usd
SCTC Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-65000 usd
CY2022Q3 SCTC Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-65000 usd
SCTC Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
31000 usd
CY2021Q3 SCTC Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
31000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_znSBJ2HWFmV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_829_zEXyK95L8Tli">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScoutCam Inc. (the “Company”), formerly known as Intellisense Solutions Inc., (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, ScoutCam Ltd. (“ScoutCam”), was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and ScoutCam consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to ScoutCam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, Intellisense and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered 100% of its holdings in ScoutCam to Intellisense in exchange for shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the consummation of the Exchange Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, Medigus beneficially owned 27.02% of the Company’s outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through ScoutCam, provides image-based platforms. Through the use of its proprietary visualization technology, ScoutCam offers solutions across predictive maintenance and condition-based monitoring markets, in sectors such as energy, automotive and aviation. ScoutCam’s solutions are based on small and highly resilient cameras, specialized AI analysis and supplementary technologies.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 60.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 9, 2021, the Company amended its Articles of Incorporation to effect a <span id="xdx_908_eus-gaap--StockholdersEquityReverseStockSplit_c20210808__20210809_zFoNTDEh2o44" title="Stockholders' equity, reverse stock split">nine-to-one</span> reverse stock split of its outstanding Common Stock. As a result of the reverse stock split, every nine shares of the Company’s outstanding Common Stock were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split. The amount of authorized capital of the Company’s Common Stock and par value of such shares remained unchanged. All share, stock option and per share information in these interim consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of the Company and through September 30, 2022, the Company accumulated a deficit of $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20220930_zqM83CJWzp5" title="Accumulated deficit">23,098</span> thousand and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources as of September 30, 2022 will enable the Company to fund its operating plan for more than 12 months from the date of issuance of these financial statements. The Company expects to continue to incur significant research and development expenses and other costs related to its ongoing operations and, as a result, will need to obtain additional funding in order to continue its future operations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. The Company considered the impact of COVID-19 on its operations and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of September 30, 2022. These estimates may change, as new events occur, and additional information is obtained.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
nine-to-one
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23098000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0198 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zsFSBWlZQhX6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zEklE462Pan3">Use of estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES </b>(continued):</span></p>
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
325000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
277000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
203000 usd
us-gaap Sublease Income
SubleaseIncome
3000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
203000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
203000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y5M19D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
52000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
194000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
40000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
292000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
277000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1253554 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
52569 shares
CY2022Q3 us-gaap Share Price
SharePrice
7.2
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
4.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2762 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
53000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.50
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.17
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1253985 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
748531 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.03
us-gaap Share Based Compensation
ShareBasedCompensation
1916000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1555000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1675000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3753000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2420000 usd
us-gaap Revenues
Revenues
222000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1675000 usd
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1130000 usd
CY2021 SCTC Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
545000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-120000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1555000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
167000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1675000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2420000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
848000 usd
SCTC Contract With Customer Liability Deferred Revenue Relating To New Sales
ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales
1616000 usd
CY2021 SCTC Contract With Customer Liability Deferred Revenue Relating To New Sales
ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales
1641000 usd
SCTC Contract With Customer Liability Revenue Recognized During Period Development Services
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriodDevelopmentServices
-211000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-72000 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-69000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3753000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2420000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3753000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
544000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
99000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
65000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
43000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
66000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
652000 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
87000 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
52000 usd

Files In Submission

Name View Source Status
0001493152-22-032059-index-headers.html Edgar Link pending
0001493152-22-032059-index.html Edgar Link pending
0001493152-22-032059.txt Edgar Link pending
0001493152-22-032059-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sctc-20220930.xsd Edgar Link pending
Show.js Edgar Link pending
sctc-20220930_pre.xml Edgar Link unprocessable
sctc-20220930_cal.xml Edgar Link unprocessable
sctc-20220930_lab.xml Edgar Link unprocessable
sctc-20220930_def.xml Edgar Link unprocessable